K. Kerr, J. S. Kuriyama, V. A. Lee, I. Miller, V. Petersen et al., International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases, J. Thorac. Oncol. Off. J. Thorac. Oncol, vol.1, issue.2, pp.244-285, 2006.

K. Takeuchi, H. Furuta, H. Asamura, and . Tsuda, The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations, Lung Cancer, vol.81, pp.371-376, 2013.

H. Budczies, W. Hoffmann, and . Weichert, The novel histologic International Association for the Study of Lung CancerEuropean Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival, J. Clin. Oncol, vol.30, pp.1438-1446, 2012.

W. D. Rusch, D. H. Travis, J. Garfield, H. L. Cadranel, D. J. West et al., Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases Bronchioloalveolar carcinoma: the case for two diseases, Mod. Pathol. Clin. Lung Cancer, vol.24, issue.9, pp.653-664, 2008.

S. Johnson and . Mentzer, Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease, J. Thorac. Cardiovasc. Surg, vol.121, pp.42-47, 2001.

P. Andrade, C. Yang, G. Casali, A. Rossi, G. Marchioni et al., Clinical features of bronchioloalveolar carcinoma with new histologic and staging definitions A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice, J. Thorac. Oncol. J. Thorac. Oncol, vol.5, issue.5, pp.1213-1220, 2010.

. Zannini, Surgical treatment of multiple primary adenocarcinomas of the lung, Thorac. Cardiovasc. Surg, vol.57, pp.30-34, 2009.

]. R. Daly, V. F. Trastek, P. C. Pairolero, P. A. Murtaugh, M. S. Huang et al., Bronchoalveolar carcinoma: Factors affecting survival, The Annals of Thoracic Surgery, vol.51, issue.3, pp.368-376, 1991.
DOI : 10.1016/0003-4975(91)90847-J

V. Vigliarolo, N. Cangemi-antoine, V. Rabbe, and J. Poulot, Comparative analysis of clinical features and prognostic factors in resected bronchioloalveolar carcinoma and adenocarcinoma of the lung, Anticancer Res, vol.23, pp.4959-4965, 2003.

M. Cadranel and . Wislez, The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation, Lung Cancer, pp.334-340, 2014.

G. Noguchi, C. A. Pelosi, M. S. Powell, I. Tsao, and . Wistuba, The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification, J. Thorac. Oncol, vol.10, pp.1243-1260, 2015.

M. Isaac-sibille and J. Lebitasy, Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib, Lung Cancer, pp.68-185, 2010.

. Ishihara, Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma, J. Thorac. Oncol, vol.5, pp.1197-1200, 2010.

E. J. Chirieac, A. J. Mark, and . Iafrate, Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features, J. Mol. Diagn, vol.9, pp.320-326, 2007.

]. Y. Sakuma, S. Matsukuma, M. Yoshihara, Y. Nakamura, K. Noda et al., Gene-Mutation Analyses for Japanese Lung Adenocarcinomas, American Journal of Clinical Pathology, vol.128, issue.1, pp.100-108, 2007.
DOI : 10.1309/WVXFGAFLAUX48DU6

M. G. Arcila, V. W. Kris, P. S. Rusch, W. D. Adusumilli, and . Travis, Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation, Am. J. Surg. Pathol, pp.38-1118, 2014.

E. Murer, S. Meschiari, A. Tamberi, F. Cadioli, M. Luppi et al., EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors, Am, J. Clin. Pathol, pp.131-478, 2009.

D. W. Kufe, Mucins in cancer: function, prognosis and therapy, Nature Reviews Cancer, vol.34, issue.12, pp.874-885, 2009.
DOI : 10.1038/nrc2761
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951677

I. Laine, P. Van-seuningen, J. R. Degand, Y. S. Gum, D. M. Kim et al., Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes, Genomics, pp.38-340, 1996.

]. N. Jonckheere and I. Van-seuningen, The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers, Biochimie, vol.92, issue.1, pp.92-93, 2010.
DOI : 10.1016/j.biochi.2009.09.018

M. C. Copin, L. Devisme, M. P. Buisine, C. H. Marquette, A. Wurtz et al., From normal respiratory mucosa to epidermoid carcinoma: expression of human mucin genes, Int. J. Cancer, pp.86-162, 2000.

]. S. Nagai, K. Takenaka, M. Sonobe, E. Ogawa, H. Wada et al., A novel classification of MUC1 expression is correlated with tumor differentiation and postoperative prognosis in non-small cell lung cancer, J. Thorac. Oncol, vol.1, pp.46-51, 2006.

]. Y. Makiguchi, Y. Hinoda, and K. Imai, Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth, Jpn, J. Cancer Res. Gann, vol.87, pp.505-511, 1996.

]. S. Ramasamy, S. Duraisamy, S. Barbashov, T. Kawano, S. Kharbanda et al., The MUC1 and Galectin-3 Oncoproteins Function in a MicroRNA-Dependent Regulatory Loop, Molecular Cell, vol.27, issue.6, pp.27-992, 2007.
DOI : 10.1016/j.molcel.2007.07.031

]. F. Guddo, A. Giatromanolaki, C. Patriarca, J. Hilkens, C. Reina et al., Depolarized expression of episialin (EMA, MUC1) in lung adenocarcinoma is associated with tumor progression, Anticancer Res, vol.18, pp.1915-1920, 1998.

T. Kondo, N. Nakajima, and . Yamamoto, Depolarized MUC1 expression is closely associated with hypoxic markers and poor outcome in resected non-small cell lung cancer, Int. J. Surg. Pathol, vol.20, pp.223-232, 2012.

. Porchet, Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas, Hum. Pathol, vol.32, pp.274-281, 2001.

]. K. Tsuta, G. Ishii, J. Nitadori, Y. Murata, T. Kodama et al., Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin, The Journal of Pathology, vol.203, issue.1, pp.78-87, 2006.
DOI : 10.1002/path.1947

H. Awaya, Y. Takeshima, M. Yamasaki, and K. Inai, Expression of MUC1, MUC2, MUC5AC, and MUC6 in Atypical Adenomatous Hyperplasia, Bronchioloalveolar Carcinoma, Adenocarcinoma With Mixed Subtypes, and Mucinous Bronchioloalveolar Carcinoma of the Lung, American Journal of Clinical Pathology, vol.121, issue.5, pp.121-644, 2004.
DOI : 10.1309/U4WGE9EBFJN6CM8R

]. S. Lantuejoul, A. G. Nicholson, G. Sartori, C. Piolat, C. Danel et al., Mucinous Cells in Type 1 Pulmonary Congenital Cystic Adenomatoid Malformation as Mucinous Bronchioloalveolar Carcinoma Precursors, The American Journal of Surgical Pathology, vol.31, issue.6, pp.31-961, 2007.
DOI : 10.1097/01.pas.0000249444.90594.27
URL : https://hal.archives-ouvertes.fr/inserm-00372219

F. Cavazza and . Rivasi, MUC5AC, cytokeratin 20 and HER2 expression and K-RAS mutations within mucinogenic growth in congenital pulmonary airway malformations, Histopathology, pp.60-1133, 2012.

]. S. Kim, A. J. Schein, and J. A. , E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells, AJP: Lung Cellular and Molecular Physiology, vol.289, issue.6
DOI : 10.1152/ajplung.00388.2004

M. Perrais, P. Pigny, M. Copin, J. Aubert, and I. , Van Seuningen, Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1, J. Biol. Chem, pp.277-32258, 2002.

H. A. Van-goudoever, J. Büller, I. Dekker, I. B. Van-seuningen, A. W. Renes et al., Muc2- deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection, Gastroenterology, pp.131-117, 2006.

J. A. Schroeder, A. A. Masri, M. C. Adriance, J. C. Tessier, K. L. Kotlarczyk et al., MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation, Oncogene, vol.23, issue.34, pp.23-5739, 2004.
DOI : 10.1038/sj.onc.1207713

]. A. Kharbanda, H. Rajabi, C. Jin, J. Tchaicha, E. Kikuchi et al., Targeting the Oncogenic MUC1-C Protein Inhibits Mutant EGFR-Mediated Signaling and Survival in Non-Small Cell Lung Cancer Cells, Clinical Cancer Research, vol.20, issue.21, pp.5423-5434, 2014.
DOI : 10.1158/1078-0432.CCR-13-3168

]. N. Jonckheere, A. Velghe, M. Ducourouble, M. Copin, I. B. Renes et al., The mouse Muc5b mucin gene is transcriptionally regulated by thyroid transcription factor-1 (TTF-1) and GATA-6 transcription factors, FEBS Journal, vol.402, issue.Pt 1, pp.278-282, 2011.
DOI : 10.1111/j.1742-4658.2010.07945.x
URL : https://hal.archives-ouvertes.fr/inserm-00807850

]. N. Nakamura, E. Miyagi, S. Murata, A. Kawaoi, and R. Katoh, Expression of Thyroid Transcription Factor-1 in Normal and Neoplastic Lung Tissues, Modern Pathology, vol.15, issue.10, pp.15-1058, 2002.
DOI : 10.1097/01.MP.0000028572.44247.CF

T. Maeda, H. Tsuchiya, D. H. Hao, Y. Tompkins, M. L. Xu et al., KrasG12D and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung, Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung, pp.4388-4400, 2012.
DOI : 10.1172/JCI64048DS1

E. L. Snyder, H. Watanabe, M. Magendantz, S. Hoersch, T. A. Chen et al., Nkx2-1 Represses a Latent Gastric Differentiation Program in Lung Adenocarcinoma, Molecular Cell, vol.50, issue.2, pp.50-185, 2013.
DOI : 10.1016/j.molcel.2013.02.018

M. Guo, K. Tomoshige, M. Meister, T. Muley, T. Fukazawa et al., Gene signature driving invasive mucinous adenocarcinoma of the lung, Mall, Y. Maeda, Gene signature driving invasive mucinous adenocarcinoma of the lung, pp.462-481, 2017.
DOI : 10.15252/emmm.201606711

K. Miyazaki, Y. Inada, M. Ueyama, H. Iwasaki, M. Inoue et al., Aberrant expression of the gastric mucin MUC6 in human pulmonary adenocarcinoma xenografts, Int. J. Oncol, pp.26-891, 2005.